35100sek
0,0 %
Date:2024-11-21Time:17:16:45Latest report:Q3-2024List:Mid CapTicker:PROB
Market Cap:3 988 msekEnterprise Value:3 720 msekNet Sales:630,4 msekEarnings:10,9 msekEmployees:0ISIN:SE0001280355

Ratios

10-year key figure history for Probi turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Probi with index and moving average MA50 and MA200.

Stockprice:351,00
MA50:268,84
MA200:243,76
Price/MA200:43,6 %
RSI (14):74,5
Price/MA50:30,2 %

Description

Probi AB is engaged in probiotic research and development, manufacturing and sales of effective and well-documented probiotics. Its research relates to living microorganisms with scientific health benefits. The main fields of research are gut health, immune system and nutrient absorption, iron absorption, bone health and stress and recovery. It operates in Consumer Healthcare (CHC) and Functional Food (FF). The company operates in United States, Americas, excluding the United States , Sweden, EMEA, excluding Sweden, and APAC. The company's business is divided into three operating segments. These segments are based on a geographical division and consist of the regions Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia and the Pacific).